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Fluid obtained from chronic and acute wounds were 
examined for the presence of fibronectin, at-anti-
trypsin, and proteinases capable of degrading both 
proteins. Immunoblot analysis of fluids from ten 
chronic wounds revealed that fibronectin and at-
antitrypsin were degraded in nine of ten samples. In 
contrast, both fibronectin and at-antitrypsin were 
intact in acute wound fluids. The degradation of the 
inhibitor and fibronectin occurred in the same wound 
fluids, and these two events correlated perfectly. 
Chronic or acute wound fluid proteins were coupled 
to benzamidine Sepharose 6B beads and incubated 
with fibronectin or at-antitrypsin. Chronic wound 
fluid proteins degraded fibronectin in the presence of 
ethylenediaminetetraacetate, leupeptin, cystatin, 
and pepstatin but not in the presence of phenylmeth-
ylsulfonyl fluoride. Acute wound fluids and normal 
human serum did not contain enzymes capable of 
degrading fibronectin. Thes~ data suggest that serine 
proteinases are responsible for fibronectin degrada-
F ibronectin (FN) and fibrin constitute the major compo-nen ts of the provisional matrix in skin wounds [1-4). These components participate in the repair process and provide substrata for migrating keratinocytes, fibro-bla sts, and endothelia l ce lls. FN is proposed to be a 
beneficial factor in the healing of skin wounds. In some chrortic, 
non- healin g wounds FN is extensively degraded [5 ,6]. The en-
zymes responsib le for 1=N degradation in chronic wounds remains 
unclear. It has been reported that chronic wound Auids contain 
increased amounts of matrix m etalloprotcinases (M.MPs)- 2 and -9 
and are involved in the degradation of FN in chroni c wounds [7]. 
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tion in chronic wound fluids. Chronic wound fluids 
that contained degraded at-antitrypsin also contain 
proteinases capable of degrading at-antitrypsin from 
human serum. Acute wound fluids and normal hu-
man serum did not contain enzymes capable of de-
grading at-antitrypsin. The inhibitor from acute 
wound fluids bound to one of its targets, trypsin. In 
contrast, the fragment(s) of at-antitrypsin from 
chronic wound fluids did not bind trypsin. Chronic 
wounds associated with degraded fibronectin and the 
inhibitor contained ten- to forty-fold more elastase 
activity than acute wounds. The degradation of fi-
bronectin by chronic wound fluid enzymes was inhib-
ited by at-antitrypsin in a dose-dependent manner. 
Collectively, these results demonstrate that there are 
enzymes in chronic wounds that perturb the function 
of at-antitrypsin and allow fibronectin degradation 
by uninhibited serine proteinases. Key words: sel'i11e 
proteinases.] I1west Dermatol 105:572-578, 1995 
But in burn-wound Aulds, Grinnell and Zhu reported that neutro-
phil e lastase, not MMPs, are responsible for FN degradation [8]. 
The aim of the experiments reported herein was to inves tigate if 
serine proteinases are responsible for FN degradation in chronic 
skin wounds and to examine the sta tus of a1 -antitryps in (AT) (also 
called a 1-protease inhibitor) [9], in acute and chronic wounds. The 
resu lts suggest that serine proteinases, not MMPs, are responsibl e 
for FN degradation in chronic wounds. Elastase activity is ten- to 
forty-fold higher in Auids fi·om chronic wounds compared to acute 
wounds and normal human serum (NHS) . The results also impli-
ca te AT as a regulator of FN degradation in chronic wounds. The 
inhibi tor protects FN from degradation by serine proteinases in 
chronic wounds. AT is intact and functiona l in acute wounds but is 
degraded and inactive in chronic wounds. AT-de!,•Tading enzymes 
were present in chronic wounds associated with degraded AT but 
absent in wound Auids with intact AT. Based on these observations. 
we propose that the loss of functional AT is responsible for F 
degradation in chronic wounds. 
MATERJALS AND METH ODS 
Collection of Chronic and Acute Wound Fluids Patien ts undergoing 
treatment for chronic venous stasis ulcers (greater than 6 n1onths duration) 
were the source of chronic wound Au ids used in this study. The procedure 
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for the co ll ection of chronic wou nd Auids was as fo ll ows. T he wo und 
dressing containin g t he ·wou nd fl uid \vas removed fro1n th e pa tien t during 
the dressi ng change . The Auid fi·01n the wound dressing was expressed 
mechanica l.ly. If the Auid could not be harvested that da y, the dressing was 
smred at - 80°C, thawed to room temperature, and then harvested. If the 
fluid from the dressi ng was minimal, 1-10 ml of normal sa line was added to 
the dressing and after 2 min the added Auid was mechanica ll y expressed. 
Acute wound fluid '"'aS obtained fi·otn aspira tes of non11 a l skin g raft d o no r 
sites covered with occl usive dressings, or fro m suction drains after breast 
surgery. 
The wou nd Auids were diluted ten fold with IS mM T ri s-HCI, pH 7.4 , 
and centrifuged in a microccntrifuge for I 0 min (12,000 X gat 4°C), T he 
clear sup e rnatant was rcn1ovcd and an ali q uo t of the s::11nplc was analyzed 
for protein dete rmination by the method of Bradford [1 0]. The typica l 
sample ra nged from 1S to 40 mg prote in per milliliter of wound Au id . 
Sodium Dodecylsulfate-Polyacrylamide Gel E lectrophoresis (SDS-
PAGE) and lnununoblotting Pro teins were separated by SDS-PAGE 
using 12% mini-gels under non-reducing conditions [11]. 
Proteins were clectroblo tted onto 1utrocellulose memb ranes as described 
before [1 2]. After blocking in 4% non-fat dry milk in 1 0 mM Tris-H C I, 150 
mM NaCI, pH 7.4, containing 0.1% Tween-20 (TTBS) for 2 h at room 
temperature, the membranes were incubated for 2 h in pre-imm une serum 
o r rabbit polyclonal antibodies to huma n AT (afli ni ty-puri fied lgG, Sigma 
Chemical Co., St. Louis, MO) o r goat polyclonal an tibodies to human 
plasma FN {purifi ed lgG, C appe l Labo ratories, Organon-Teknika Corp ., 
West C heste r, PA) di luted ·1 :500 in TTBS. After three 5-min washes, the 
membranes were incubated for ·1 h with peroxidase-conjugated secondary 
antibody (afliniry-puriticd lgG- horseradish-peroxidase-conjugated , goat 
anti-rabbit for FN and rabbit anti-goat for AT, Bio-Rad Research Labora-
tories, Richmo nd , CA) diluted 1: l 000 in TTBS. T he antibody-binding 
p roteins were iden tified by using the 4- chloro-naptha l m embrane peroxi-
dase substra te system (IGrkegaard and Perry Laboratories, Gaithersburg, 
MD). 
Coupling of Wound Fluid Proteins to Bcnzamidine Sepharose 6B 
Two hundred fift)' microLiters of packed benzamidine Sepharose 6B (BZ-
6B) beads (Pharmacia-LKB Biotechnology Inc .. Uppsa la, Sweden; lots 
214844 and 2 l 99S6) were washed four times with 15 mM Tris-HCI, pH 
7.40 {incubation buffer). T he beads we re incubated wi th 150 /.!1 wound Auid 
sample or NI-lS en l .S ml of incubation buffer for 1 h at room temperature. 
The beads were pell etcd by brief centrifugation in a microcentrifuge, 
w ash ed three times with incubation buffer, and resuspended in 15 mM 
Tris-HCI, pH 7.40, 5 mM CaCI2 , 5 mM MgCI2 . 
Degradation of FN by Wound Fluid Proteins in the Presence or 
Absence of Proteinase Inhibitors BZ-6B complexed with proteins 
from wound Auids and NHS were resuspe nded in 400 JLI of 15 mM 
Tris-HCI, pH 7.4, 5 mM CaCI0 , 5 mM MgCI2 , 1S mM eth ylenediaminetet-
raacetic acid (EDTA) or 1S mM Tris-HCI, pH 7 .40, 5 mM C aCI2 , and 5 
mM MgCI2 containing one of the fo llowing inhibitors: 20 J.Lg C)'Statin , 20 ILg 
leupepti.n , 20 ILg pepstatin , or l 0 mM phenylmethylsulfonyl fluoride 
(PMSF). W hen these fo ur inhibitors were used, they were added 20 min 
prior co the addition of 10 to 30 ILg of human plasma FN (New York B lood 
Center, NY). T he reaction mixtu.res were incubated fo r different periods of 
time or for 6 h as described in figure legends. At the end of each time point, 
the supernatant was collected by centrifugation of the beads, dilu ted to 1 X 
with S X SDS-PAGE sample buffer and FN fragments were detected by 
immunoblotting with anti-FN antibodies or SDS-PAGE with silver stain. At 
the end of so n1c cxpcrin1ents , the bead s were resuspend ed _in 2 X 
SDS-PAGE sam ple buffer and the extract anal yzed by immunoblotting with 
a.nti-FN antibodies , as describcd above. 
Trypsin Afti.nity Chromatography of Chronic and Acute W ound 
Fluid Proteins Trypsin (2 mg/ ml) was couplcd to Reactigd aga rosc 
beads fo llowing the man ufi1cturer's instructio ns (Pierce C hemica l Co. , 
Rockford, IL). Five hundred microliters of 1: I 0 dilu ted NHS or wou nd 
flu id samplcs were incuba ted with ·1 00 ILl of tryps in-l"leactigcl beads tha t 
w ere prev io usly equ ilibrated in :IS mM Tris-H C I, pH 7.4 (eq uilibration 
buffer) . The incubation was continucd tor 1 h at room te mperature with 
end- over-e nd rota t io n. T he supe rnatant was rcrnovcd and th e trypsin-
Reactigel beads were washed th ree timcs with equilibration buffer. Trypsin 
bound proteins were extracted in to I SO ,.,.1 o r Laemmli 's 2 X SDS-PAGE 
sample b u ffer witho ut /3-mcrcaptoethano l. AT or fragnu:n ts of AT were 
derccted by immunoblo tting w ith anti-AT anti body. 
Degradation ofFN b y Proteins from Chronic Wound Fluids in the 
Presence of AT BZ-6B (50 pJ packed volume) complexcd with chronic 
wo und Auid prote ins were resuspended in 200 ILl of IS mM T ris-HCI. pH 
7.4, 5 mM CaCI2 , S mM MgC I2 containing 25 to "12S ILg AT (Sigma). After 
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Figure 1. Extensive degradation of FN in chronic wound fluids 
(CW) but not acute wound fluids (A W) . Twenty-five micrograms of 
proteins from NHS, acute, and chronic wound Au ids were separated on 12% 
polyacrylamide gels , transferred to nitrocellulose membranes, and immu-
noblotted with goat po lyclona l antibodies to FN. The detail s of immuno-
blotting are described in Materials n11d Methods. 
a 20-min incubation with the inhibitor, 15 ILg of FN was added to the 
reaction n1ixturc and .inc ubaccd fo r 8 h w ith end-over- end rotation. 
Supernatants were co ll ected by centrifugation , diluted to l X with 5 X 
SDS-PAGE sample buffer, and FN polypeptides were detected by immu-
no blotting with anti-FN antibody, as described above. 
D egradation of AT by Enzymes from Chronic Wound Fluids O ne 
hund red micro lite rs of BZ-6B complexcd w ith proteins fro m NHS, acute , 
or chronic wound Auids were incubated in 350 JLI ofTris-HCI. pH 7.40, 5 
mM CaCI2 , 5 mM MgCI2 containing 400 ILg of normal human serum 
proteins (as the so urce of AT) . T he beads were allowed to react with AT for 
different periods of time. Seventy-microli ter portions of the clear superna-
ta nt were coll ected at 0 min , 30 min. 2 h, 4 h, and 20 h. T he supernatant was 
adj usted to 1 X by diluting the sample with 5 X SDS-PAGE sample buffer 
w itho ut /3-mercaptoethanol. Fragments of AT were detected in 30 JLI 
portions of the su pernatants by immunoblotting with anti- AT antibody. 
Qua ntitation of Elastase in Wound F luids Elastase levels were 
quantitated in NHS, acute, and chronic wound fluids as described before [8] 
using methoxysuccinyl-ala- ala-pro-val-p-nitroan ilide (Sigma) as the sub-
strate. One hundred micrograms of proteins from wound fluid samples or 
0.05 mU to 0.5 mU of human leukocyte elastase {EC 3.4.21.37 ., Sigma) 
were incubated in 0.1 M HEPES buffer, pH 7.30, containing 0.5 M NaCI, 
10% dimethylsul foxide, and 0. 1. mM elastase substrate for 1 h at room 
temperature. Substrate degradation was measured at 410 nm using a 
Beckman 640 spectrophotometer. Wound fluid elastase levels were read 
against a standard curve obtained with leukocyte ela tase and are expressed 
as milliuni ts per milligram of wound Auid proteins. 
RESULTS 
Extensive Degradation ofFN in Chronic Wounds Prote im 
from three acute wounds, ten chronic wounds, and NHS were 
subjected to SDS-PAGE and immunoblotting agaimt anti-FN 
antibodies. Under n o n-reducing conditions, purified plasm a FN h as 
a m o lecular size of 440 k.Da and bare ly penetrated th e 12% 
polyac ry lamide ge ls (data n ot sh own). L ike NHS, acute wound 
fluid s large ly contained in tact FN (Fig 1, lan es marked NHS, 
AWl, AW2, AW3 and AW4). In con trast to th e acute wound 
fluids, nin e of ten sampl es of proteins from chro nic wounds 
con ta ined FN fragm e n ts with molecular sizes between 20 and 140 
kDa (Fig 1 , C W 2- C W1 0). T h e o n ly exception was c hro nic wound 
Auid marked cw·1, whic h contained largely intac t FN (lane CW :I ). 
FN was also intact in three bliste r Auids and o n e addi tiona l a ute 
wound Auid (data n ot shown ). T h ese results con firm those of 
G rinnell and co-worke rs [5,6], w h o also re ported that FN was 
large ly in tact in acute wounds whereas it was exten sively d egraded 
in som e chro nic wounds. 
Degradation ofFN b y Chronic Wound Fluid Enzymes Was 
Not Inhibited b y EDTA T h e enzymes in chronic wounds 
thought to be responsible for FN d egradation are MMPs 2 and 9 
[7] . However , we fo und n o corre lation between FN degrad ation 
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Figure 2 . Chronic wound fluids (CW) contain serine proteinascs 
that arc responsible for the degradation of huma n plasma FN. 
Proteins fro m CW3, CW4 . CW5, CW6 . CW7, CW8, CW9, and CW10 
were coupled to benza midine Sepharose 6B (DZ-6B) . T he beads were 
incubated w ith human ph1sma FN (25 {J.g) in a tota l volume of 400 fLI 
contain ing 15 mM T ris-1-!CI, pH 7.4, 5 mM CaCI 2 , 5 mM MgCI20 10 mM 
EDTA (for lanes 1-5 in all the panels) at room temperature. Eighty-
tnicroli tcr il liquots of the supernatants were rc n1oved at v~uious tin1e po in ts 
to w hi ch 20 I·LI of5 X SDS-PAGE sample buffe r •.vas added. A 30-p.l aliquot 
was ana lyzed by immunoblotting w ith polyclona l antiserum to FN . In all the 
pane ls, lnues I to 5 represent the time of incubatio n : lnue I. 0 min ; lnue 2. 30 
m in ; lnue 3, 120 min; ln111: 4, 240 min ; and lnuc 5. 16 h . T he abi li ty of PMSF, 
cystatin.lcupeptin , and pepstati.n to inhibi t the degradatio n of FN by DZ-6ll 
containin g chro i1i c wound Auid enzyn1 cs was pc rforrncd in inc ubation 
buffer w itho ut EDTA. T he degrad ation of FN was te rminated after 6 h . 
Laues 6 to 9 rep resent the fo llowing inh ibito rs: lntll' 6, 10 m M PMSF; lnuc 7, 
20 {J.g cysta tin; lnue 8. 20 p.g leupeptin ; and ln111• 9, 20 {J.g pepstarin. 
and the gelatinolytic activities of pro- and activated MMP-2 and -9 
in acute and chronic wound fluids (Rao, unpublished observations). 
To demonstrate that MMPs are not responsibl e for FN degrada tion 
in chronic wounds, the degradation of FN by chronic wound fluid 
enzymes was performed in the presence o f EDT A, a potent 
inhibitor of M~MPs . Proteins from acute and chronic wounds and 
NHS were coupled to BZ-6B beads and in cubated with FN in 
presence of EDT A. Degradation of FN occurred by BZ-6B beads 
compl exed with proteins from nine of ten chronic wound Au ids. At 
0 min, FN was in tact (Fig 2, lane 1 of all panels) . In cubation ofFN 
with these beads for 30 min (lane 2), 2 h (lane 3), 4 h (lane 4), and 
16 h (lane 5) resulted in the appearance of specific FN fragme nts 
(20-120 kDa) that progressively increased (lanes 2 through 5 of all 
panels). Identica l resu lts were obtained when the degradation of 
FN was carried o ut in the absence o f EDTA (data not shown). FN 
fragments were also detected by SDS-PAGE with a sensitive silve r 
sta in reagent. By this techniq ue, FN was fragmented into polypep-
tides of14, 26, 28, 31, 34 , 39, 40, 45, and 55 kDa (data not shown). 
Coll ectively, these results demonstrate that MMPs are not respon-
sible for FN degrada tion in chronic wo und fluid s associated with 
degraded FN. 
FN Degrading Proteinases Are Not Present in Acute 
Wound Fluids, CW1, and NHS W hen proteim from acute 
wound fluids, NHS, and CW1 were coupled to BZ-6B, they fa iled 
to degrade FN. No FN fragments were detected (Fig 3 , lanes 2-5). 
In some samples FN is lost with increas ing time o f in cubation (lanes 
3 to 5). In all these cases, i~nta ct FN was detected on BZ- 6B beads 
(data not shown). Sim ilar results were obtained w hen these exper-
iments were ca rried out in the absence of EDT A. (data not shown). 
The possibility of any FN fragments that cannot be detected by 
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Figure 3. Acute wound fluids AWl, AW2, and AW3, normal 
hutnan serum, and CWl do not contain e n zymes capable of 
degrading FN. T he experimenta l conditions were ide n tica l to those in Fig 
2 . Lntll' ·t, 0 min ; laue 2, 30 min; lnuc J . 120 min; lnue 4, 4 h ; and lnuc 5, 16 
h after incubation of FN. 
an ti-FN antibody was also considered. No FN fragments were 
de tected by SDS-PAGE with a sensitive silver stain reagent (data 
not shown). T hus, acute wound fluids, NHS, and C W1 did not 
conta in FN degrading enzymes. 
Serine Proteinascs in Chronic Wound F luids Are Respon-
sible for F N Degradation To identify enzymes responsible for 
FN degradation in chronic woun d fluids, degradation of FN by 
chronic wound fluid proteins was performed in the presence of 
serine- , cyste ine- , and acid-p roteinase inhibitors. Incubation of FN 
with protei ns fi·om chronic wound fluids in the presence (Fig 2 , all 
panels, lanes 6-9) of these inhibi tors was allowed for 6 h. FN 
degradation was completely inhibi ted b y 10 mM PMSF (Fig 2, lane 
6 of all panels) but no inhibition occurred in the presence of20 J.Lg 
of cysta tin, leupeptin, and pcpstatin (Fig 2, lanes 7, 8, and 9 of all 
pa nels, respectively). Beca use PM SF is a specific inhibitor of se rine 
proteinases [13], we conclude that th is class of enzymes is respon-
sible fo r FN degradation in chronic wound fluids . Further, leupep-
tin, wh ich is an inhibitor of trypsin-l ike proteinases, f.~i l ed to inhibi t 
the degradation of FN by chron ic wound fluid enzymes . This 
observation points to an e lastase- or chymotrypsin-like enzyme 
like ly responsible for FN degradation in chronic wounds. These 
observations arc in agreement with those of Grinnell and Zhu [8] 
who reported that a serine proteinase, preferabl y an elastase- or 
chymotrypsin-like enzyme, is respons ibl e for FN degradation in 
burn-wound fluid s. 
AT Is Degraded in Chronic Wound Fluids But Intact in 
Acute Wound Fluids Beca use a serine proteinase class of 
enzymes is responsible fo r FN degradation in chronic wound fluids 
we sought to investigate if serum serine proteinase inhibitors 
(se rpins), particularly AT [9] , were intact and functional in chronjc 
wounds . 
As shown in Fig 4, AT was degraded to a major 37-kDa 
polypeptide in aiJ chronic wou nds i.n which degraded FN was 
observed w hereas the AT was in tact in wounds without degraded 
FN . Like AT, other set-pin s, namely, antichymotrypsin, antithrom-
bin Ill , and a2-an tiplasmin, were also degraded in wound fluids in 
which there was degraded FN and intact in w hich FN was largely 
intact (Rao, unpublished data) . In a number of lanes (Fig 4) 
particu larly w ith chronic wound fluid samples , anti-AT antibodies 
also labeled proteins of 90 kDa and higher. Most likely, these are 
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Figure 4. at-antitrypsin (AT) is degraded in chronic wound fluids 
(CW) but intact in acute wound fluids (A W). Twenty micrograms o( 
proteins fron1 NI-lS . acute. and chronic wo und fluid s were transferred ti·o1n 
12o/o polyacrylamide gels to nitrocellulose membra nes and immunoblotted 
with rabbit polyclona l antibodies to human AT. 
aggregates of AT, as it was !mown to polymerize, which was also 
observed with pure AT (lane m arked AT). 
Trypsin Does Not Bind Fragments of AT in Chronic Wound 
Fluids Although AT was not intact in chronic wounds associated 
with degraded FN , AT fragm ents were o bserved. To determine if 
these fragme nts are capable ofbinding to trypsin, we incubated 1.5 
mg of acute and chronic wound fluid proteins w ith trypsin-
Seph arose. Trypsin is one of the targets of AT [9]. Any bound 
iulllbito r was identifi ed by immun oblotting the trypsin-Sepharose 
bound proteins aga inst anti-AT an tibo di es. Acute wound fluids 
NHS and CW1 subjected to immun o blotting produ ced a 50-kDa 
band labe led by the an ti- AT antibodies (Fig 5). In contrast, 
fragment(s) of AT from CW4, CW5, and CW2 did not bind 
trypsin (Fig 5). In CW3, CW6, CW7, CW8, and CWlO, the 
amo unt o f the 37-kDa AT fragment and AT recovered from 
t.rypsin-Sepharose was seven- to tenfo ld less compared to the AT 
from NHS and acute wound Auids. T he refore, these experiments 
f' suggest that AT is functio nal in acute wo unds w hereas the frag-
ments o f AT in chronic wounds assoc iated with degraded FN were 
non- functional. 
Degradation of FN by Chronic Wound Fluid Protcinases 
Was Inhibited by AT To assess which serpin protects FN fi:om 
degradation by chro nic wound Auid enzymes, AT, anti chymotryp-
sin, antithro mbin Ill , and a2- antiplasmin were added to reaction 
mixtures con taining FN and BZ-6B bound proteins fi·om chronic 
wound Auids. In cubation of FN for 8 h with the BZ-6B bound 
proteins from six chronic woun ds resul ted in the appearance ofFN 
fragme nts rang ing between 120 kJ)a and 10 kDa (Fig 6, lane 2 of 
all pane ls). In contrast, when the degradation of FN was carried o u t 
in the presence of 5 J.Lg (a ll pan els, lane 3) and 20 J.Lg (a ll panels , 
lane 4) of AT, it was protected from degradation. Ev idence for the 
inhibition ofFN degradation by AT were twofold : 1) in tact FN was 
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Figure 5. Thirty-seven kilodalton fragment of AT from chronic 
wound fluids (CW) docs not bind trypsin . CW and acute wound (A W) 
fluids were allowed to bind trypsin and the bound prote ins were eluted into 
150 J.Ll ofSDS-PAGE sample buffer. An aliquot (30 J.LI) was analyzed by 12% 
SDS- PAGE and immunoblotted with polyclona l antibodies to AT. T he 
deta.ils arc in 1\t/nterin/s n11d Methods. 
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F igure 6. AT inhibits the degradation o f plasma FN by chronic 
wound flu id enzymes. BZ-613 containing proteins fi-om CW2. CW3. 
C\V6, CW9, and CW IO were incubated with increasing amoun ts (30 J,Lg 
and 120 J,Lg) of AT or without the inhibitor to r 20 min in 15 mM Tris-1-I CI, 
pH 7 .4 , 5 mM MgCI0 , and 5 mM CaCI 2 at room temperature. Then 15 J,Lg 
of pure plasma FN was added (final vo lume 200 J.LI) and the reaction 
mixtures incubated for 8 h at room temperature with end-over-end 
ro t·<ltio n . T he reactio n rni xturcs \ovcrc cen trifuged and 30-~J,I portions were 
inlnlunoblottcd \Vith FN an tise rum. Lnm• J\11 1-'V, tn o lccul nr \Veight tnarkcrs: 
ln11e 1, undegraded FN: ln11e 2, 8 h digest of FN: ln11e 3, 8 h digest of FN in 
the presence of 5 J,Lg AT; and ln11e 4, 8 h digest of FN in the presence of 20 
J,Lg AT. 
in creased in the presence of inhibi tor and 2) certain lower molec-
ul ar weigh t FN fragm en ts between 25 and 45 kDa were not 
produced in the presence of inhibi tor. A ntichym otrypsin and 
a2-antiplasmin a lso protected FN fro m degradation (data not 
shown) but to a lesser extent w hen compared to AT. Based on 
these resu lts, it appears that AT was the sa Li en t scrpin capable of 
protecting FN from degradation by chronic wound Auid serin e 
p rotein ases. 
Elastase Levels Were Ten- to F ortyfold Higher in Chronic 
Wound Fluids Compared to Acute Wound F luids Because 
e lastase degrades FN iu 11i /ro and has been shown to be the 
responsibl e enzym e degrading FN in burn wound fluid s [8], elastase 
activ ity in acu te and chronic wound Auids was quantitated _ E ht stase 
levels in acute wound fluids (0 .1 to 0.3 mU / m g of protein) were 
compa rable to those in NI--lS (0.15 to 0.17 mU/ mg of protein) 
(Table I) . In contrast, chronic wound Auids assoc iated with 
degraded FN contains ten- to fortyfold m o re e las tase activity (3 to 
8 mU/ mg protein) (Table 1). 
AT-Degrading Enzymes Arc Present in Chronic Wound 
Fluids Associated with Degraded AT Because AT is de-
graded in chronic wound fluids assoc iated with degraded FN and it 
was shown to protect FN fi-om degradation by chronic wou nd Auid 
enzym es, we w ished to determine if AT degrading enzymes arc 
present in wound fluid s associa ted with degraded AT. To address 
this qu estion , wo und Auid proteins were coupl ed to BZ-6B and 
in cubated w ith NHS as the sou rce of AT. As shown in Fig 7, 
BZ-6B complexed w ith proteins from NHS, and A W2 did not 
degrade AT (Fig 7 , lanes 2- 5 of pa ne ls NHS and A W2). In 
contrast, degradation of AT readi ly occurred with beads containing 
proteins fi-om chron ic wounds (Fig 7 , lan es 2-5 of pane ls CW3, 
CW6, CW5, and CW7). AT was detected as a 50-kDa protein at 
0 min of incubation of the serum with BZ-6B coupled with chronic 
wound fluids (lane 1 )- Increasing the incubation tim e to 30 min 
(lane 2), 2 h (lane 3), 5 h (lane 4), <tnd ovemight (lane 5) resu lted 
in th e appearance of 40- and 35- kDa fi-agm en ts. AT antibodies also 
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Table I. Elastase Activity in Acute and Chronic Wound 
Fluids'' 
Elastase Activity 
Sample (mU/mg Protein) 
NHS 0.19 
AWl 0.17 
AW2 0.33 
AW3 0.30 
AW4 0.20 
CW2 5.26 
CW3 2. 75 
CW4 3.70 
CW5 7.00 
CW6 5.15 
CW7 4.15 
CWB 3.65 
CW9 4.75 
11 The assay conditions and the measurement of the enzyme arc described in Nfntcrifl ls 
all(/ A1etltods. The values represent rhe avc[i]gc of two determinations, which differed 
between 0 and 7 percent. 
label a 6-kDa (marked by arrowheads in CW6 and CW7) and an 
8-kDa polypeptide in serum proteins after an overnight incubation 
(lane 5). The degradation of AT by enzymes !Tom chronic wound 
fluids was further evidenced by a gradual decrease in the molecular 
size of AT with incubation time (lanes 2-4) and the complete 
disappearance of the inhibitor in the serum after overnight incuba-
tion (lane 5). T hese data clearly demonstrate that chronic wound 
fluid s with degraded AT also contain enzymes capable of degrading 
AT. 
Klla MW 1 
66-
45-
31 -
21-
14-
NHS 
3 4 5 
CW3 
MW12345 
CW6 
MW 1 3 5 
AW2 
MW 1 3 4 5 
cws 
MW 1 3 4 5 
---
CW7 
MW 1 3 5 
- '--"-
-- - ... 
Figure 7. Chronic wound fluids contain enzymes capable of de-
grading human AT. Proteins from Nl-15. acute wound (AW) Auid-1, and 
CW3, CWS, CW6, and C W7 were coupled to 13Z-6B and incubated with 
400 /Jog human sen1111 proteins as dcsc1·ibcd in Mnterin ls ami Methods . 
Supernatants of the reaction mixtures were coll ected at 0 min (/mil' / ), 30 
min (lnuc 2) . 2 h (lnue 3) , 5 h (/nur 4) . and 20 h (laue 5) and were 
immunoblotted with polyclonal antibodies to human AT. 
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WOUNDS 
Acute Chronic 
I I 
"AT" Degrading Enzymes are Absent " AT" Degrading Enzymes are Present 
I I 
"AT" is Intact and Functional "AT" is Degraded and Non-Functional 
I I 
Elastase Levels are Normal Elastase Levels are Significantly Higher 
I I 
Intact "FN" Degradation of "FN" 
Figure 8. Predicted sequence of events leadit1g to FN degradation 
in chronic wounds. 
DISCUSSION 
The results of this series of experiments presents an interes ting 
hypothesis that explains why FN is degraded in chronic wounds 
(Fig 8) . The chain of events begin s with the express ion of one or 
more enzymes in chronic wounds associated with degraded FN , but 
not in acute wounds, which can degrade AT. The degraded AT in 
chronic wound fluids was non-functional. Elastase, the physiologic 
target of AT, was 10 to 40 times higher in chronic wound fluids. 
Thus, the non-functional AT fragments are incapabl e of inhibiting 
the serine proteinases (neutrophil e lastase) that are responsible for 
FN degradation in chronic wounds. 
W e were able to demonstrate the existence of AT- and FN-
degrading enzymes in wounds associated with degraded FN and AT 
but not in wounds associated with intact FN and AT. We have also 
been able to demonstrate that the degradation of FN by chronic 
wound fluid enzymes was effec tively inhibited by AT. These 
observations were possible beca use of the use of BZ-6B to bind 
wound fluid proteins including enzymes. BZ-6B are covalently 
linked w ith a trypsin inhibitor, P-aminobenzamidine, and have 
been used for purification and/ or separation of trypsin, bovine 
thrombin, urokinase, human enterokinase, native plasminogen, 
kallikrein, prekaUikrein, collagenase, and clostripain [14-16). Al-
though BZ-6B are covalently associated with a trypsin inhibitor, the 
enzymes from chronic wound fluids were active and have repro-
ducibly degraded both FN and AT. Coupling the wound fluid 
prote ins to BZ-6B not only e liminated the need to account for the 
existing FN and AT fragments, but also enabled us to examine the 
degradation of FN and AT by immunoblotting and si lver stain 
procedures. In addition, any proteinase inhibitors of the wound 
fluids would not interfere with the abili ty of the wound fluid 
enzymes to degrade FN and AT. 
Our results sugges t that th e degradation of AT, by as yet 
unidentified enzymes, leads to loss of this inhibitor in wounds that 
eventually feature extensive FN degradation . Degradation of AT 
W<lS observed in pa tients with pulmonary emphysema [17-20) and 
rheumatoid arthri tis [21-23) . A number of enzymes of mammalian 
and bacterial origin degrade AT i11 vitro. Of the mammalian 
enzymes, MMP-8 [24-26), MMP-1 [27), MMP-3 (28,29), MMP-7 
[29), and MMP-9 [30] have been shown to contain AT -degrading 
activity. Mouse macrophage elastase, a neutral metalloprote inase 
(31 J and human polymorphonuclear leukocyte collagenase (3 2) also 
degra de AT. Mast el a/ [3 3 J compared the rates of degradation of 
AT, antichymotrypsin , and antithrombin 11'1 b)' MMP-1, MMP-2, 
and MMP-3 and suggested that MMP-3 is a more likely physiologic 
enzyme-inactivatin g serum serpins. More recently, Z hang el nl [30] 
reported that MMP-7 degraded native as well as oxidized AT four 
times faster th an MMP-3. In addition to MMPs, cathepsin L, a 
lysosomal thiol-proteinase, also degrades AT (34] . 
A number of bacterial enzymes have also been reported to 
degrade AT. These proteinases include metalloproteinase from 
Seretin Jllnrccsce11s [35], serine-, cyste ine-, and metalloprotc inases 
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from Stnpltylowcws n11re11s [36], and a neutral m etalloproteinase/ 
elastase from Pselldc>>IIOIIns t~cmgi11osn [37]. It has been shown that 
metabolites derived from S. a11re11s and P. ncmgi11 osn impede wound 
healing [38]. In particul ar, the presence of P. neru_gi11osn has been 
found to correlate with non-healing necrotic ulcers [39]. Potempa 
et nl [36] proposed that the inactivation of AT by pathogenic 
bacteria is an e fFective m echanism for altet;ng AT -neutrophil 
elastase balance in blood to favor ft·ee enzyme and increase plasma 
protein degradation associated with septicemia. W c observed that 
chronjc wound fluids w ith extensive FN degradation conta in a 
42- k.Da gelatinolytic enzyme (Rao , unpublished data). It wi ll be 
interesting to investiga te if this enzyme is responsible tor the 
degradation of AT in chronic wounds . 
Degradation of AT ma y also contribute to chronic inflammation 
associated with non-hea ling chroni c wounds. Banda et nl [40] 
demonstrated a novel fun ction for the proteolyti ca lly modifi ed AT. 
In contrast to native AT, mouse macrophage elastase-treated AT 
undergoes proteolysis and acts as a potent chemotactic factor for 
hu man n eutrophils. Thus, proteol ys is of AT can contribute to 
pro.longed inflammation by recrui ting more inflammatory cells to 
the sites of chronic wou nds. Inflammatory ce ll s are a lso the primary 
source of elastase, w hich has been shown to degrade FN i11 11itro 
[8,41]. Although our experiments do not prec isely identify elastase 
as the enzyme responsible for FN degradation, the following 
findings suggest that it is the responsibl e enzym e : 1) the enzyme 
levels w e re ten- to fortyfold highe r in chronj c wound fluids 
compared to acute wound fluids, and 2) it has been identified as the 
enzym e respon sibl e for FN degradation in burn wound fluids [8]. 
Coll ective ly, these observations provide us with a basis to propose 
that the express ion o f AT -degrading enzymes (neutrophi l and/ or 
bacterial) in chronic wounds alters the balance between AT and 
elas tase toward an enzyme-t;ch environment, resulting in uncon-
trolled degradation of FN in chronj c wounds . A similar imbalance 
in proteinase-proteinase inhibitor levels leads to inc reased connec-
tive tissue degradation in patients with pulmonary emphysema [18] 
and rheumatoid arthri tis [22). 
The observations reported here in ma y have re levance for the 
trea tm ent of chronic wounds. Several studies demonstrated a 
ben eficial e ffec t fo r topical FN on leg ulcers and non-hea ling 
con1ea l ulcers [42-44] . Intact FN may be required fo r the hea.ling 
of chronic wounds. The observations reported he rein suggest that 
the degradation of AT precedes th e degradation of FN in chronic 
wo unds. We show here that AT effectively prevented the degra-
dation of FN by chronic wound fluid serine prote ina ses. T herefore, 
topica l AT may inhibi t FN degrading enzym es and inc rease the 
concentration of intact and fun ctional FN in chronic wounds. In 
conclusion , we report that chronic wound fluids associated with 
exten sive ly degraded FN arc associated w ith degraded AT and 
AT-degrading enzymes. AT inhibited the degradation of FN by 
chronic wound fluid enzymes, suggestin g that this inhibitor regu-
lates FN degradation in chroni c wounds. 
l¥e thauk Dr. S lumm Stack )or critical rcadiu.~ of this 1/llllll<.<eril'l. 
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